Transcend Medical Closes $51M Series B Financing
14. Juli 2011 08:00 ET
|
Transcend Medical
MENLO PARK, CA--(Marketwire - Jul 14, 2011) - Transcend Medical, Inc., an ophthalmic device company dedicated to developing minimally invasive glaucoma therapies, announced the closure of its second...
Sunshine Heart Completes Feasibility Study for Fully-Implantable C-Pulse(R) Heart Assist System
08. Juni 2011 18:53 ET
|
Sunshine Heart, Inc.
MINNEAPOLIS, MN--(Marketwire - Jun 8, 2011) - Sunshine Heart, Inc. (ASX: SHC), a global medical device company focused on innovative technologies for Class III/ambulatory Class IV (moderate to...
Neuronetics, Inc. Raises $30 Million in Series E Financing
16. Mai 2011 08:30 ET
|
Neuronetics
MALVERN, PA--(Marketwire - May 16, 2011) - Neuronetics, Inc., maker of the NeuroStar TMS (Transcranial Magnetic Stimulation) Therapy® System for the treatment of major depression*, announced today...
New Trial Data Confirm Clinical Effectiveness and Good Adherence Rates With NeuroStar TMS Therapy in Patients With Major Depressive Disorder Treated in a Real World Practice Setting
15. Mai 2011 19:00 ET
|
Neuronetics
HONOLULU, HI--(Marketwire - May 15, 2011) - Results of a Neuronetics-sponsored, multisite observational study of patients with major depressive disorder (MDD) treated with Neuronetics' NeuroStar...
Neuronetics Receives TiE50 Award for Technology Entrepreneurship
09. Mai 2011 08:30 ET
|
Neuronetics
MALVERN, PA--(Marketwire - May 9, 2011) - Neuronetics, Inc., maker of the NeuroStar Transcranial Magnetic Stimulation (TMS) Therapy® System, has been selected by TiE Silicon Valley as a 2011 recipient...
New Data Show No Negative Long-Term Effect in Cognitive Function in Patients With Major Depressive Disorder Treated With NeuroStar TMS Therapy(R)
14. April 2011 13:30 ET
|
Neuronetics
HONOLULU, HI--(Marketwire - Apr 14, 2011) - In an open-label study of patients with major depressive disorder (MDD) who had not benefitted from prior antidepressant medication and were treated with...
Sunshine Heart Receives Approval to Expand C-Pulse(R) Heart Assist System Study
10. April 2011 19:00 ET
|
Sunshine Heart, Inc.
MINNEAPOLIS, MN--(Marketwire - Apr 10, 2011) - Sunshine Heart, Inc. (ASX: SHC), a global medical device company focused on innovative technologies for Class III/ambulatory Class IV (moderate to...
Sunshine Heart Announces Completion of Enrollment of 20 Patients for C-Pulse(R) Heart Assist System
03. April 2011 19:00 ET
|
Sunshine Heart, Inc.
MINNEAPOLIS, MN--(Marketwire - April 3, 2011) - Sunshine Heart, Inc. (ASX: SHC), a global medical device company focused on innovative technologies for moderate to severe heart failure, today...
CoActive Health Communications Names Vice President to Lead and Grow United States Client Services
21. März 2011 08:30 ET
|
CoActive health Communications
SAN FRANCISCO, CA--(Marketwire - March 21, 2011) - CoActive Health Communications, an award-winning full-service healthcare communications firm, today announced that Amy Berry, a...
Neuronetics Appoints Vice President of Health Policy and Government Relations
02. März 2011 08:00 ET
|
Neuronetics
MALVERN, PA--(Marketwire - March 2, 2011) - Neuronetics, Inc. today announced that Mary Hailey, an industry executive with more than 25 years of experience in designing and implementing healthcare...